J Clin Immunol (2018) 38:96–128 https://doi.org/10.1007/s10875-017-0464-9 ORIGINAL ARTICLE International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity Capucine Picard 1,2 & H. Bobby Gaspar 3 & Waleed Al-Herz 4 & Aziz Bousfiha 5 & Jean-Laurent Casanova 6,7,8,9 & Talal Chatila 10 & Yanick J. Crow 11,12 & Charlotte Cunningham-Rundles 13 & Amos Etzioni 14 & Jose Luis Franco 15 & Steven M. Holland 16 & Christoph Klein 17 & Tomohiro Morio 18 & Hans D. Ochs 19 & Eric Oksenhendler 20 & Jennifer Puck 21 & Mimi L. K. Tang 22,23,24 & Stuart G. Tangye 25,26 & Troy R. Torgerson 19 & Kathleen E. Sullivan 27 Received: 19 July 2017 / Accepted: 31 October 2017 / Published online: 11 December 2017 # The Author(s) 2017. This article is an open access publication Abstract Beginning in 1970, a committee was constituted under the auspices of the World Health Organization (WHO) to catalog primary immunodeficiencies. Twenty years later, the International Union of Immunological Societies (IUIS) took the remit of this committee. The current report details the categorization and listing of 354 (as of February 2017) inborn errors of immunity. The growth and increasing complexity of the field have been impressive, encompassing an * Kathleen E. Sullivan sullivank@email.chop.edu 11 Laboratory of Neuroinflammation and Neurogenetics, Necker Branch, INSERM UMR1163, Paris Descartes University, Sorbonne-Paris-Cité, Institut Imagine, Paris, France 1 Center for the Study of Immunodeficiencies, Necker Hospital for Sick Children, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France 12 2 Laboratory of Lymphocyte Activation and Susceptibility to EBV, INSERM UMR1163, Imagine Institute, Necker Hospital for Sick Children, Paris Descartes University, Paris, France Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK 13 Departments of Medicine and Pediatrics, Mount Sinai School of Medicine, NewYork, NY, USA UCL Great Ormond Street Institute of Child Health, London, UK 14 Ruth’s Children’s Hospital-Technion, Haifa, Israel 4 Department of Pediatrics, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait 15 Grupo de Inmunodeficiencias Primarias, Facultad de Medicina, Universidad de Antioquia UdeA, Medellin, Colombia 5 Laboratoire d’Immunologie Clinique, d’Inflammation et d’Allergy LICIA Clinical Immunology Unit, Casablanca Children’s Hospital, Ibn Rochd Medical School, King Hassan II University, Casablanca, Morocco 16 Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA 17 Dr von Hauner Children’s Hospital, Ludwig-Maximilians-University Munich, Munich, Germany 18 Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan 19 Department of Pediatrics, University of Washington and Seattle Children’s Research Institute, Seattle, WA, USA 20 Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, University Paris Diderot, Sorbonne Paris Cité, Paris, France 21 Department of Pediatrics, University of California San Francisco and UCSF Benioff Children’s Hospital, San Francisco, CA, USA 22 Murdoch Children’s Research Institute, Melbourne, VIC, Australia 3 6 St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA 7 Howard Hughes Medical Institute, New York, NY, USA 8 Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR1163, Imagine Institute, Necker Hospital for Sick Children, University Paris Descartes, Paris, France 9 10 Pediatric Hematology-Immunology Unit, Necker Hospital for Sick Children APHP, Paris, France Division of Immunology, Children’s Hospital Boston, Boston, MA, USA J Clin Immunol (2018) 38:96–128 97 increasing variety of conditions, and the classification described here will serve as a critical reference for immunologists and researchers worldwide. Keywords IUIS . primary immune deficiency . immune dysregulation . autoinflammatory disorders Introduction In 1970, Drs. Fudenberg, Good, Hitzig, Kunkel, Roitt, Rosen, Rowe, Seligmann, and Soothill met under the auspices of the World Health Organization to classify the emerging “primary immune deficiencies.” This august group focused on understanding whether immunodeficiencies could be categorized as B cell disorders or T cell disorders [1, 2]. Their initial report identified 16 distinct immunodeficiencies and included the prophetic comment that “the variable immunodeficiency group probably lumps together a series of syndromes…. Included in this group are cases previously classified as ‘congenital’, non-sex linked or sporadic hypogammaglobulinemia, primary ‘dysgammglobulinemia’ of both childhood and adult life, and ‘acquired’ primary hypogammaglobulinemia. It is hoped that careful analysis of such patients…. will result in delineation of several homogeneous syndromes…”. I n d e e d , t h e e m e rg e n c e o f m o n o g e n i c c a u s e s o f hypogammaglobulinemia (Table 3) and disorders with variable immunoglobulin abnormalities associated with immune dysregulation (Table 4) have been the groups of immunodeficiencies most transformed by the advent of new technologies. Another group dramatically impacted by resetting of the clinical radar and new techniques has been the set of disorders associated with a limited spectrum of infectious susceptibility. The graphs in Fig. 1 define the transformation of the field over the interval during which next-generation sequencing came to prominence. The tremendous progress, energy, and enthusiasm in the field currently have led to a greater need than ever for a current cataloging of the disorders. 23 Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia 24 Department of Allergy and Immunology, Royal Children’s Hospital, Melbourne, Australia 25 Immunology Division, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia 26 St Vincent’s Clinical School, University of NSW, Sydney, Australia 27 Division of Allergy Immunology, Department of Pediatrics, The Children’s Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, ARC 1216-I 3615 Civic Center Blvd, Philadelphia, PA 19104, USA Fig. 1 Each publication of the World Health Organization and IUIS Primary Immunodeficiencies Committee was reviewed for the number of conditions listed and displayed graphically [1–19]. The rapid increase in the twenty-first century relates to improved awareness and increasing use of sequencing. Assuming 20,000 coding genes in the human genome, inborn errors of immunity are implicated through mutations in 1.7% of these genes. There are now 330 specific disorders, 320 monogenic defects, 312 distinct genes (nine genes with both LOF and GOF and C4 deficiency requiring defects in both C4A and C4B). a The categorization of the inborn errors of immunity according the schema in the current manuscript. b The categorization of the inborn errors of immunity according to their inheritance The new disorders (since 2015 [3]) represent an impressive spectrum of phenotypes. There are 354 distinct disorders with 344 different gene defects listed. The emerging dominance of next-generation sequencing has driven the rapid increase in the number of recognized disorders which has led to two major consequences. Often new inborn errors of immunity are initially described in a single kindred or a small number of kindreds. This may lead to incorrect assumptions about prevalence and phenotype. In fact, for most disorders, we have little idea of the prevalence within even the recognized population with the described phenotype. The second consequence of the rapid rise of nextgeneration sequencing is a striking expansion of the phenotypic spectrum associated with many diseases. Where once Genetic defect AR AR AR AR AR AR AR AR RAG1 RAG2 DCLRE1C PRKDC NHEJ1 LIG4 AK2 ADA 176977 611290 601837 103020 608958 Very low Very low Very low Very low Very low 179615 Very low 179616 Very low 605988 Very low AR AR CD40 (TNFRSF5) ICOS CD3G CD8A ZAP70 TAP1 TAP2 TAPBP B2M CD40 deficiency ICOS deficiency CD3γ deficiency CD8 deficiency ZAP-70 deficiency (ZAP70 LOF) MHC class I deficiency MHC class I deficiency MHC class I deficiency MHC class I deficiency AR AR AR AR AR AR AR CD40LG (TNFSF5) CD40 ligand deficiency (CD154) XL 176947 Low CD8, Nl CD4 number but poor function 170260 Low CD8, Nl CD4, absent MHC I on lymphocytes 170261 Low CD8, Nl CD4, absent MHC I on lymphocytes 601962 Low CD8, Nl CD4, absent MHC I on lymphocytes 109700 186740 Nl number, but low TCR expression 186910 Absent CD8, nl CD4 604558 Normal 109535 Normal 300386 Nl to low 3. Combined immunodeficiencies generally less profound than severe combined immunodeficiency DOCK2 deficiency DOCK2 AR 603122 Low 2. T-B- SCID RAG1 deficiency RAG2 deficiency DCLRE1C (Artemis) deficiency DNA PKcs deficiency Cernunnos/XLF deficiency DNA ligase IV deficiency Reticular dysgenesis Adenosine deaminase (ADA) deficiency IgM normal or high, other Ig isotypes low sIgM+, IgD+ cells present, absent sIgG+, IgA+ and IgE+ cells Normal Normal Normal Normal Normal Normal Normal Normal Normal Normal Normal Normal Normal Normal Low IgM normal or high, other Ig isotypes low sIgM+, IgD+ cells present, absent sIgG+, IgA+, and IgE+ cells Normal IgG Nl or low, poor antibody responses Variable Decreased Decreased Decreased Low, decreasing Decreased Decreased Decreased Low Low Low Low Low Low Low High Low Ig Normal Very low Very low Very low Nl to low Low, decreasing Very low Very low Very low Normal to high Normal to high Normal Normal Normal Normal Normal Nl to low 600173 146661 151460 186790 186830 186780 605000 602354 Very low Very low Very low Very low Very low Very low Very low Nl to low number Normal to high B cells 308380 Very low Inheritance OMIM T cells Immunodeficiencies affecting cellular and humoral immunity 1. T-B+ severe combined immune deficiency (SCID) IL2RG XL γc deficiency (common gamma chain SCID, CD132 deficiency) JAK3 deficiency JAK3 AR IL7Rα deficiency IL7R AR CD45 deficiency PTPRC AR CD3δ deficiency CD3D AR CD3ε deficiency CD3E AR CD3ζ deficiency CD247 AR Coronin-1A deficiency CORO1A AR LAT deficiency LAT AR Disease Table 1 Vasculitis, pyoderma gangrenosum Vasculitis, pyoderma gangrenosum Recurrent infections, may be asymptomatic May have immune dysregulation, autoimmunity Vasculitis, pyoderma gangrenosum Nl NK cells, but defective function. Poor interferon responses in hematopoietic and non-hematopoietic cells Neutropenia, thrombocytopenia, hemolytic anemia, opportunistic infections, biliary tract and liver disease, Cryptosporidium infections Neutropenia, opportunistic infections, gastrointestinal and biliary tract and liver disease, Cryptosporidium infections Recurrent infections, autoimmunity, gastroenteritis, granulomas Nl NK, radiation sensitive, microcephaly Nl NK, radiation sensitive, microcephaly Nl NK, radiation sensitive, microcephaly Granulocytopenia and deafness Low NK, bone defects, may have pulmonary alveolar proteinosis, cognitive defects Nl NK Nl NK Nl NK, radiation sensitive Low NK Nl NK Nl γ/δ Τ cells Nl NK, no γ/δ T cells Nl NK, no γ/δ T cells Nl NK, no γ/δ T cells Detectable thymus, EBV Adenopathy, splenomegaly, recurrent infections, autoimmunity Low NK Associated features 98 J Clin Immunol (2018) 38:96–128 CIITA RFXANK RFX5 RFXAP DOCK8 RHOH STK4 TRAC LCK MALT1 CARD11 BCL10 BCL11B IL21 IL21R TNFRSF4 MHC class II deficiency group B MHC class II deficiency group C MHC class II deficiency group D DOCK8 deficiency Rhoh deficiency MST1 deficiency TCRα deficiency LCK deficiency MALT1 deficiency CARD11 deficiency (LOF) BCL10 deficiency BCL11B deficiency IL-21 deficiency IL-21R deficiency OX40 deficiency Genetic defect MHC class II deficiency group A Disease Table 1 (continued) AR AR AR AD AR AR AR AR AR AR AR AR AR AR AR AR Nl to low Normal 615207 Nl number, low cytokine production, poor antigen proliferation 615593 Nl numbers, low antigen specific memory CD4+ 615767 Nl number, nl/low function 615206 Nl number, predominant naïve T cells, poor proliferation 616098 Nl number, low memory T and Treg cells, poor antigen and anti-CD3 proliferation 617237 Low, poor proliferation Normal 615758 Low CD4+, low Treg, restricted T cell repertoire, poor TCR signaling 615468 Nl number, poor proliferation Low IgG Normal Low Nl levels, poor specific antibody response Absent/low Nl IgG and IgA, high IgM Normal Nl number, poor specific antibody responses Nl numbers, low memory B cells Normal Normal Low Normal Nl number, decreased memory and switched B cells Normal, transitional B cell predominance Normal Normal 615387 Absent TCRαβ, all T cells are γδ, poor proliferation High Normal Low IgM, Nl to high IgG and IgA, high IgE Nl to low Normal Low, low CD27+ memory B cells Poor peripheral B cell tolerance Nl to low Nl to low Ig Normal Normal B cells Normal 602037 Nl number, low naïve T cells, restricted repertoire, poor proliferation to CD3 614868 Low, low terminal differentiated Low effector memory (TEMRA) cells, low naïve T cells, poor proliferation 600005 Low CD4 cells Absent MHC II expression on lymphocytes 603200 Low CD4 cells Absent MHC II expression on lymphocytes 601863 Low CD4 cells Absent MHC II expression on lymphocytes 601861 Low CD4 cells Absent MHC II expression on lymphocytes 243700 Low, poor proliferation, few, poorly functioning Treg Low CD8, Nl CD4, absent MHC I on lymphocytes Inheritance OMIM T cells Congenital abnormalities, neonatal teeth, dysmorphic facies, absent corpus callosum, neurocognitive deficits Severe early-onset colitis, recurrent sinopulmonary infections Recurrent infections, Pneumocystis jiroveci, Cryptosporidium infections and liver disease Impaired immunity to HHV8, Kaposi’s sarcoma Recurrent bacterial and viral infections, candidiasis, gastroenteritis Pneumocystis jirovecii pneumonia, bacterial and viral infections Bacterial, fungal and viral infections Respiratory and gastrointestinal infections, liver/biliary tract disease Respiratory and gastrointestinal infections, liver/biliary tract disease Low NK cells with poor function, eosinophilia, recurrent infections, cutaneous viral, fungal and staphylococcal infections, severe atopy, cancer diathesis HPV infection, lung granulomas, molluscum contagiosum, lymphoma Intermittent neutropenia, bacterial, viral (HPV), candidal infections, EBV lymphoproliferation, autoimmune cytopenias, lymphoma, congenital heart disease Recurrent viral, bacterial, fungal infections, immune dysregulation and autoimmunity, diarrhea Recurrent infections, immune dysregulation, autoimmunity Respiratory and gastrointestinal infections, liver/biliary tract disease Sinopulmonary infections, cutaneous granulomas. Absent β2m associated proteins MHC I, CD1a, CD1b, CD1c Respiratory and gastrointestinal infections, liver/biliary tract disease Associated features J Clin Immunol (2018) 38:96–128 99 MAP3K14 RELB MSN TFRC NIK deficiency RelB deficiency Moesin deficiency TFRC deficiency AR XL AR AR AR 604758 Nl number, poor diversity, poor function 300988 Nl number, defective migration, proliferation 616740 Nl number, poor proliferation 615592 Nl number, absent Treg and γ/δ T cells, impaired TCR activation 604655 Nl number, poor proliferation to antigen Inheritance OMIM T cells Nl number, low memory B cells Low number Low Low Ig’s over time Low Ig’s Low Nl number, poor function Low, low switched memory B cells Ig B cells Recurrent infections with bacteria, varicella, neutropenia Recurrent infections, neutropenia, thrombocytopenia Low NK number and function, recurrent bacterial, viral and Cryptosporidium infections Recurrent infections Recurrent bacterial, viral, fungal infections, opportunistic infections Associated features SCID severe combined immunodeficiency, EBV Epstein-Barr virus, MHC major histocompatibility complex, HPV human papillomavirus, Treg T regulatory cell, Nl normal, XL X-linked inheritance, AR autosomal recessive inheritance, AD autosomal dominant inheritance, LOF loss-of-function SCID/CID spectrum: Infants with SCID who have maternal T cell engraftment may have T cells in normal numbers that do not function normally; these cells may cause autoimmune cytopenias or graft versus host disease. Hypomorphic mutations in several of the genes that cause SCID may result in Omenn syndrome (OS), or “leaky” SCID, or still less profound combined immunodeficiency (CID) phenotypes. Both OS and leaky SCID can be associated with > 300 autologous T cells/μL of peripheral blood and reduced, rather than absent, proliferative responses when compared with typical SCID caused by null mutations. A spectrum of clinical findings including typical SCID, OS, leaky SCID, CID, granulomas with T lymphopenia, autoimmunity and CD4 T lymphopenia can be found in an allelic series of RAG1 and other SCID-associated genes. Total number of disorders in Table 1: 49 (17 SCID, 32 CID). New disorders: 5, MOESIN, BCL11B, TFRC, RELB, LAT. Removed gene: UNC119 deficiency has been removed. The UNC119 variant reported previously is a benign polymorphism in unaffected individuals IKBKB Genetic defect IKBKB deficiency Disease Table 1 (continued) 100 J Clin Immunol (2018) 38:96–128 Genetic defect Inheritance AR AR AR CDCA7 HELLS PMS2 RNF168 AR ZBTB24 RNF168 deficiency (radiosensitivity, immune deficiency, AR DNMT3B Immunodeficiency with centromeric instability and facial anomalies, ICF1 Immunodeficiency with centromeric instability and facial anomalies, ICF2 Immunodeficiency with centromeric instability and facial anomalies, ICF3 Immunodeficiency with centromeric instability and facial anomalies, ICF4 PMS2 deficiency AR AR BLM (RECQL3) Bloom Syndrome AR NBS1 Nijmegen breakage syndrome 612688 600259 603946 609937 614064 602900 604610 602667 607585 2. DNA repair defects other than those listed in Table 1 Ataxia-telangiectasia ATM AR 602357 604223 ARPC1B ARPC1B deficiency AR AR WIPF1 WIP deficiency 300392 OMIM Normal Normal Decreased or normal responses to PHA may be decreased Decreased or normal, Decreased or normal, responses to PHA may be decreased Normal Progressive decrease Progressive decrease, abnormal proliferation to mitogens Reduced, defective lymphocyte responses to anti-CD3 Normal Progressive decrease in numbers, abnormal lymphocyte responses to anti-CD3 T cells Combined immunodeficiencies with associated or syndromic features 1. Immunodeficiency with congenital thrombocytopenia Wiskott-Aldrich WAS XL syndrome (WAS LOF) Disease Table 2 Normal Low B cells, switched and non-switched Decreased or normal Decreased or normal Decreased or normal Decreased or normal Normal Variably reduced Normal Normal numbers Normal or low Normal numbers B cells Low IgG and IgA, high IgM, abnormal antibody responses Low IgG or IgA Hypogammaglobulinemia or agammaglobulinemia, variable antibody deficiency Hypogammaglobulinemia or agammaglobulinemia, variable antibody deficiency Hypogammaglobulinemia or agammaglobulinemia, variable antibody deficiency Hypogammaglobulinemia or agammaglobulinemia, variable antibody deficiency Often low IgA, IgE, and IgG subclasses, increased IgM, antibodies variably decreased Low Often low IgA, IgE and IgG subclasses, increased IgM monomers, antibodies variably decreased Normal except for high IgA and IgE Normal, except for high IgE Low IgM and antibody responses to polysaccharides, often high IgA and IgE Ig Short stature, mild defect of motor control to ataxia, normal intelligence to learning difficulties, mild Recurrent infections, café-au-lait spots, lymphoma, colorectal carcinoma, brain tumors Short stature, dysmorphic facies, sun-sensitive erythema, marrow failure, leukemia, lymphoma, chromosomal instability Ataxia, telangiectasia, pulmonary infections, lymphoreticular and other malignancies, increased alpha fetoprotein, increased radiosensitivity, chromosomal instability and chromosomal translocations Microcephaly, dysmorphic facies, lymphomas, solid tumors, increased radiosensitivity, chromosomal instability Thrombocytopenia with small platelets, recurrent bacterial and viral infections, bloody diarrhea, eczema, lymphoma, autoimmune disease, IgA nephropathy, vasculitis. XL thrombocytopenia is a mild form of WAS, and XL neutropenia is caused by missense mutations in the GTPase binding domain of WASp Thrombocytopenia with or without small platelets, recurrent bacterial and viral infections, eczema, bloody diarrhea, WAS protein absent Mild thrombocytopenia with normal sized platelets, recurrent invasive infections, colitis, vasculitis, autoantibodies (ANA, ANCA), eosinophilia, defective Arp2/3, filament branching Associated features J Clin Immunol (2018) 38:96–128 101 AR 600838 601362 AR AD SEMA3E Unknown FOXN1 Del10p13-p14 CHARGE syndrome Winged helix nude FOXN1 deficiency AD 608166 608892 CHARGE syndrome due to SEMA3E deficiency AD CHD7 602054 CHARGE syndrome due to CHD7 deficiency AD Very low Decreased or normal, response to PHA may be decreased Decreased or normal, response to PHA may be decreased Decreased or normal, response to PHA may be decreased Decreased or normal Normal Decreased or normal TBX1 Normal Decreased or normal, 5% have < 1500 CD3T cells/μL in neonatal period 602054 Normal Normal Decreased Normal or decreased Normal Normal Normal or decreased Normal or decreased Normal or decreased Normal or decreased Normal or decreased High IgA, low IgM and IgG Low IgA and IgG Reduced antibody responses Normal Decreased Ab responses to PPS normal IgG, IgA, elevated IgM Normal Hypogammaglobulinemia Low IgG2 and IgM, lack of antibody to PPS Normal Ig Normal Normal Normal Low or normal Low or normal 610608 Low Normal Normal Very low Low memory B cells Normal B cells Lymphopenia Lymphopenia, lack of TRECS, absent proliferation in response to antigens Lymphopenia, decreased mitogen response Number decreased, poor response to mitogens and antigens Decreased T cell proliferation Normal T cells 615667 608243 126391 602670 174762 602638 OMIM TBX1 deficiency ERCC6L2 (Hebo ERCC6L2 AR deficiency) GINS1 deficiency GINS1 AR 3. Thymic defects with additional congenital anomalies DiGeorge/velocardiofac- Large deletion AD ial syndrome (3 Mb) Chromosome 22q11.2 typically in deletion syndrome chromosome (22q11.2DS) 22 DiGeorge/velocardiofacial Unknown Sporadic syndrome NSMCE3 NSMCE3 deficiency AR AR POLE2 LIG1 AR AR Inheritance POLE MCM4 Genetic defect Ligase I deficiency POLE1 (polymerase ε subunit 1) deficiency (FILS syndrome) POLE2 (polymerase ε subunit 2) deficiency dysmorphic features, learning difficulties [RIDDLE] syndrome) MCM4 deficiency Disease Table 2 (continued) Hypoparathyroidism, conotruncal cardiac malformation, velopalatal insufficiency, abnormal facies, intellectual disability Hypoparathyroidism, conotruncal cardiac malformation, velopalatal insufficiency, abnormal facies, intellectual disability Coloboma, heart anomaly, choanal atresia, intellectual disability, genital and ear anomalies, CNS malformation, some are SCID-like and have low TRECs Coloboma, heart anomaly, choanal atresia, intellectual retardation, genital and ear anomalies, CNS malformation, some are SCID-like and have low TRECs Coloboma, heart anomaly, choanal atresia, intellectual disability, genital and ear anomalies, CNS malformation, some are SCID-like and have low TRECs Severe infections, abnormal thymic epithelium, immunodeficiency, congenital alopecia, nail dystrophy, neural tube defect Hypoparathyroidism, conotruncal cardiac malformation, velopalatal insufficiency, abnormal facies, intellectual disability Facial dysmorphism, microcephaly, bone marrow failure Neutropenia, IUGR, NK cells very low Recurrent respiratory infections, growth retardation, sun sensitivity, lymphoma, radiation sensitivity Severe lung disease (possibly viral), thymic hypoplasia, chromosomal breakage, radiation sensitivity Recurrent infections, disseminated BCG infections, autoimmunity (type 1 diabetes, hypothyroidism, facial dysmorphism NK cells: low number and function. Viral infections (EBV, HSV, VZV), short stature, B cell lymphoma, adrenal failure Recurrent respiratory infections, meningitis, facial dysmorphism, livido, short stature facial dysmorphism to microcephaly, increased radiosensitivity Associated features 102 J Clin Immunol (2018) 38:96–128 Genetic defect MYSM1 RNU4ATAC EXTL3 MYSM1 deficiency MOPD1 deficiency EXTL3 deficiency PGM3 PGM3 deficiency AR AR AD LOF AR AR AR AR AR Inheritance 172100 605010 102582 601428 612176 606622 157660 OMIM 6. Dyskeratosis congenita (DKC), myelodysplasia, short telomeres XL-DKC due to DKC1 XL 300126 dyskerin deficiency SPINK5 Comel-Netherton syndrome 5. Hyper IgE syndromes (HIES) AD-HIES STAT3 STAT3 deficiency (Job syndrome) SMARCAL1 Schimke immuno-osseous dysplasia 4. Immuno-osseous dysplasias Cartilage hair hypoplasia RMRP (CHH) Chromosome 10p13-p14 deletion Syndrome (10p13-p14DS) Disease Table 2 (continued) Progressive decrease CD8 and CD4 T cells may be decreased Normal Normal overall, Th-17 and T-follicular helper cells decreased Reduced Normal T cell lymphopenia, reduced naïve T cells Decreased Varies from severely decreased (SCID) to normal, impaired lymphocyte proliferation Normal, rarely lymphopenia and decreased lymphoproliferation to mitogens and antigens, hypolastic thymus may be present T cells Progressive decrease Low B and memory B cells Low Switched and non-switched B cells Normal, reduced switched and non-switched memory B cells, BAFF expression increased Normal Normal Immature B cells Normal Normal B cells Variable hypogammaglobulinemia Normal or elevated IgG and IgA, most high IgE, eosinophilia High IgE and IgA Antibody variably decreased High IgE, specific antibody production decreased Variably decreased Normal, specific antibodies variably decreased Hypogammaglobulinemia Normal Normal or reduced, antibodies variably decreased Ig Intrauterine growth retardation, microcephaly, nail dystrophy, sparse scalp hair and eyelashes, hyperpigmentation of skin, palmar Distinctive facial features (broad nasal bridge), bacterial infections (boils and pulmonary abscesses, pneumatoceles) due to S. aureus, pulmonary aspergillus, Pneumocystis jirovecii, eczema, mucocutaneous candidiasis, hyperextensible joints, osteoporosis and bone fractures, scoliosis, retention of primary teeth, coronary and cerebral aneurysm formation Congenital ichthyosis, bamboo hair, atopic diathesis, increased bacterial infections, failure to thrive Severe atopy, autoimmunity, bacterial and viral infections, skeletal anomalies dysplasia: short stature, brachydactyly, dysmorphic facial features, and intellectual disability cognitive impairment, hypomyelination Short-limbed dwarfism with metaphyseal dysostosis, sparse hair, bone marrow failure, autoimmunity, susceptibility to lymphoma and other cancers, impaired spermatogenesis, neuronal dysplasia of the intestine Short stature, spondiloepiphyseal dysplasia, intrauterine growth retardation, nephropathy, bacterial, viral, fungal infections, may present as SCID, bone marrow failure Short stature, recurrent infections, congenital bone marrow failure, myelodysplasia, immunodeficiency affecting B cells and granulocytes, skeletal anomalies, cataracts, developmental delay. Recurrent bacterial infections, lymphadenopathy, spondyloepiphyseal dysplasia, extreme intrauterine growth retardation, retinal dystrophy, facial dysmorphism, may present with microcephaly Platyspondyly, kyphosis, variable skeletal dysplasias, developmental delay Hypoparathyroidism, renal disease, deafness, growth retardation, facial dysmorphism, cardiac defects may be present, recurrent infections +/− Associated features J Clin Immunol (2018) 38:96–128 103 AD AD or AR AR AR (AD?) AR AR TINF2 TPP1 DCLRE1B/SNM1/APOLLO: PARN WRAP53 STN1 SAMD9L AD or AR TERT SAMD9L AD TERC SAMD9 AD or AR RTEL1 SAMD9 AR NOP10 AD (GOF) AD (GOF) AR AR NHP2 CTC1 Inheritance Genetic defect Coats plus syndrome due to CTC1 deficiency AR-DKC due to PARN deficiency AR-DKC due to WRAP53 deficiency Coats plus syndrome due to STN1 deficiency AR-DKC due to nucleolar protein family A member 2 (NHP2) deficiency AR-DKC due to nucleolar protein family A member 3 (NHP3) or NOP10 deficiency AD/AR-DKC due to regulator of telomere elongation (RTEL1) deficiency AD-DKC due to TERC deficiency AD/AR-DKC due to TERT deficiency AD-DKC due to TINF2 deficiency AD/AR-DKC due to TPP1 deficiency AR-DKC due to DCLRE1B deficiency Disease Table 2 (continued) 159550 617053 613129 613128 612661 604212 609683 609377 604319 187270 602322 608833 606471 606470 OMIM Normal Not reported Normal Variable Not reported Variable Variable Variable Variable Variable Variable Decreased Decreased Decreased T cells Low Not reported Normal Variable Not reported Variable Variable Variable Variable Variable Variable Variable Variable Variable B cells Not reported Not reported Normal Not known Not reported Variable Variable Variable Variable Variable Variable Variable Variable Variable Ig Intrauterine growth retardation, premature aging, pancytopenia, hypocellular bone marrow, gastrointestinal hemorrhage due to vascular ectasia, intracranial calcification, abnormal telomeres Intrauterine growth retardation, sparse graying hair, dystrophic nails, trilinear bone marrow failure, osteopenia, gastrointestinal hemorrhage due to vascular ectasia, retinal telangiectasia, intracranial calcification, abnormal telomeres IUGR with gonadal abnormalities, adrenal failure, MDS with chromosome 7 aberrations, predisposition to infections, enteropathy, absent spleen hyperkeratosis, premalignant oral leukoplakia, pancytopenia, myelodysplasia, +/− recurrent infections. A severe phenotype with developmental delay and cerebellar hypoplasia known as Hoyeraal-Hreidarsson syndrome (HHS) may occur in some DKC patients Associated features 104 J Clin Immunol (2018) 38:96–128 Genetic defect AR Inheritance 613441 OMIM AR SP110 EPG5 HOIL1 (RBCK1) RNF31 Hepatic veno-occlusive disease with immunodeficiency (VODI) Vici syndrome due to EPG5 deficiency HOIL1 deficiency HOIP deficiency AR AR AR AR TTC7A AR AR AD GOF AR STIM1 ORAI1 IKBA (NFKBIA) PNP 10. Other defects Purine nucleoside phosphorylase (PNP) deficiency Immunodeficiency with multiple intestinal atresias STIM1 deficiency 9. Calcium channel defects ORAI-1 deficiency EDA-ID due to IKBA GOF mutation Normal Low memory and isotype switched B cells Normal or decreased, TCR activation impaired 612487 Normal numbers Normal numbers Profound depletion of CD4+ cells 615068 610924 Normal (decreased memory T cells) Variable, but sometimes absent low TRECs Progressive decrease Normal, defective TCR mediated activation Normal, defective TCR mediated activation Normal, decreased memory B cells Defective Normal (decreased memory B cells) Normal or low Normal Normal Normal Normal B cell numbers, impaired BCR activation, low memory and isotype switched B cells Low Low thymic output, normal in vitro proliferation Normal total T cells, TCR activation impaired Variable Variable B cells Variable numbers and activation profile Normal T cells 604457 609332 164050 605921 610277 164008 SLC46A1 AR 229050 SLC46A1/PCFT deficiency causing hereditary folate malabsorption Methylene-tetrahydrofo- MTHFD1 AR 172460 late dehydrogenase 1 (MTHFD1) deficiency 8. Anhidrotic ectodermodysplasia with immunodeficiency (EDA-ID)) EDA-ID due to NEMO NEMO (IKBKG) XL 300248 /IKBKG deficiency (ectodermal dysplasia, immune deficiency) 7. Defects of vitamin B12 and folate metabolism Transcobalamin 2 TCN2 deficiency Disease Table 2 (continued) Poor antibody responses to polysaccharides decreased Decreased (particularly IgG2) Decreased IgG, IgA, IgM, absent germinal centers and tissue plasma cells Markedly decreased IgG, IgM, IgA Normal or low Normal Normal Decreased, some with elevated IgA, IgM, poor specific antibody responses, absent antibody to polysaccharide antigens Decreased IgG and IgA, elevated IgM, poor specific antibody responses, absent antibody to polysaccharide antigens Decreased/poor antibody responses to conjugated polysaccharide antigens Decreased Decreased Ig Bacterial (sepsis), fungal, viral infections, multiple intestinal atresias, often with intrauterine polyhydramnios and early demise, some with SCID phenotype Hepatic veno-occlusive disease, Susceptibility to Pneumocystis jirovecii pneumonia, CMV, candida, thrombocytopenia, hepatosplenomegaly, cerebrospinal leukodystrophy Agenesis of the corpus callosum, cataracts, cardiomyopathy, skin hypopigmentation, intellectual disability, microcephaly, recurrent infections, chronic mucocutaneous candidiasis Bacterial infections, autoinflammation, amylopectinosis Autoimmune hemolytic anemia, neurological impairment Autoimmunity, EDA, non-progressive myopathy Autoimmunity, EDA, non-progressive myopathy Anhidrotic ectodermal dysplasia, various infections (bacteria, mycobacteria, viruses and fungi), colitis, variable defects of skin, hair and teeth, T cell and monocyte dysfunction Anhidrotic ectodermal dysplasia (in some), various infections (bacteria, mycobacteria, viruses and fungi), colitis, conical teeth, variable defects of skin, hair and teeth, monocyte dysfunction Recurrent bacterial infection, Pneumocystis jirovecii, megaloblastic anemia, neutropenia, seizures, intellectual disability, folate-responsive Megaloblastic anemia, pancytopenia, if untreated for prolonged periods results in intellectual disability Megaloblastic anemia, if untreated for prolonged periods results in intellectual disability Cytopenia, predisposition to MDS with chromosome 7 aberrations, immunodeficiency, and progressive cerebellar dysfunction Associated features J Clin Immunol (2018) 38:96–128 105 XL (females may be affected) 300128 602113 604260 612411 612753 OMIM Normal Normal Modestly decreased Low/variable Low/variable T cells Normal Normal Normal Low IgA and occasionally IgG Low IgA and occasionally low IgG Normal decreased decreased Normal, decreased memory B cells Low/variable Low/variable Ig B cells Growth-hormone insensitive dwarfism, dysmorphic features, eczema, lymphocytic interstitial pneumonitis, autoimmunity Typical facial abnormalities, cleft or high arched palate, skeletal abnormalities, short stature, intellectual disability, congenital heart defects, recurrent infections (otitis media, pneumonia) in 50% of patients. Autoimmunity may be present Lymphangiectasia and lymphedema with facial abnormalities and other dysmorphic features Bacterial infections, autoinflammation, amylopectinosis, lymphangiectasia Lymphangiectasia and lymphedema with facial abnormalities and other dysmorphic features Associated features IUGR intrauterine growth retardation, HSV herpes simplex virus, VZV varicella zoster virus, BCG Bacillus Calmette-Guerin, XL X-linked inheritance, AR autosomal recessive inheritance, AD autosomal dominant inheritance, LOF loss-of-function, GOF gain-of-function Pure bone marrow failure syndromes have not been included. Total number of disorders in Table 2: 67. New disorders: 23, ARPC1B, CDCA7, HELLS, POLE2, LIG1, GINS1, NSMCE3, ERCC6L2, TBX1, MYSM1, MOPD1, STN1, CTC1, KMT2D, KDM6A, SAMD9, SAMD9L, EXTL3, WRAP53, FAT4. Unknown cause of DiGeorge syndrome, unknown cause CHARGE, 10p13-14 deletion KDM6A Kabuki syndrome 2 due to KDM6A deficiency AR STAT5B AD AR FAT4 KMT2D (MLL2) AR Inheritance CCBE1 Genetic defect Kabuki syndrome 1 due to KMT2D deficiency Hennekam-lymphangiectasia-lymphedema syndrome due to CCBE1 deficiency Hennekam-lymphangiectasia-lymphedema syndrome due to FAT4 deficiency STAT5b deficiency Disease Table 2 (continued) 106 J Clin Immunol (2018) 38:96–128 Genetic defect Predominantly antibody deficiencies Inheritance OMIM Ig CD79A CD79B BLNK PIK3R1 Igα deficiency Igβ deficiency BLNK deficiency PIK3R1 deficiency AR AR AR AR AR 171833 604515 147245 112205 146770 All isotypes decreased All isotypes decreased All isotypes decreased All isotypes decreased All isotypes decreased Unknown PIK3CD GOF PIK3R1 PTEN CD19 CD81 MS4A1 CR2 TNFRSF13B (TACI) TNFRSF13C (BAFF-R) Common variable immune deficiency with no gene defect specified (CVID) PIK3CD mutation (GOF) PIK3R1 deficiency (LOF) PTEN Deficiency (LOF) CD19 deficiency CD81 deficiency CD20 deficiency CD21 deficiency TACI deficiency BAFF receptor deficiency AD or AR AR AR AR AR AD AR AD AD Variable 604907 606269 120650 112210 186845 601728 107265 616005 602839 Low IgG, normal or elevated IgM and IgA Low IgG, impaired anti-pneumococcal response Low IgG and IgA and/or IgM Low IgG and IgM, Low IgG, low or normal IgA and IgM Decreased Low IgG and IgA and/or IgM All isotypes decreased All isotypes decreased Low IgG and IgA and/or IgM E47 transcription factor TCF3 AD 147141 All isotypes decreased deficiency 2. Severe reduction in at least 2 serum immunoglobulin isotypes with normal or low number of B cells, CVID phenotype IGLL1 λ5 deficiency 1. Severe reduction in all serum immunoglobulin isotypes with profoundly decreased or absent B cells, agammaglobulinemia BTK XL 300300 All isotypes decreased in majority of BTK deficiency, X-linked patients, some patients have agammaglobulinemia detectable immunoglobulins (XLA) μ heavy chain deficiency IGHM AR 147020 All isotypes decreased Disease Table 3 Variable clinical expression Variable clinical expression Recurrent infections Recurrent infections, may have glomerulonephritis Recurrent infections Lymphoproliferation, autoimmunity Recurrent infections, may have glomerulonephritis Clinical phenotypes vary: most have recurrent infections, some have polyclonal lymphoproliferation, autoimmune cytopenias and/or granulomatous disease Severe bacterial infections; decreased or absent pro-B cells, EBV Severe bacterial infections, pro-B cells present and low numbers of memory B cells, EBV Severe bacterial infections, normal numbers of pro-B cells Severe bacterial infections, decreased or absent pro-B cells Recurrent bacterial infections Severe bacterial infections, normal numbers of pro-B cells Severe bacterial infections, normal numbers of pro-B cells Severe bacterial infections, normal numbers of pro-B cells Severe bacterial infections, normal numbers of pro-B cells Severe bacterial infections, normal numbers of pro-B cells Associated features J Clin Immunol (2018) 38:96–128 107 AR MOGS (GCS1) TRNT1 TTC37 NFKB1 NFKB2 IKZF1 IRF2BP2 ATP6AP1 Mannosyl-oligosaccharide glucosidase deficiency (MOGS) TRNT1 deficiency TTC37 deficiency NFKB1 deficiency NFKB2 deficiency IKAROS deficiency IRF2BP2 deficiency ATP6AP1 deficiency 300197 615332 603023 615577 164011 614649 612907 601336 602695 OMIM INO80 MSH6 INO80 MSH6 AR AR AR Ig heavy chain mutations and deletions Mutation or chromosomal deletion at 14q32 AR 4. Isotype, light chain, or functional deficiencies with generally normal numbers of B cells UNG UNG deficiency 610169 600678 191525 3. Severe reduction in serum IgG and IgA with normal/elevated IgM and normal numbers of B cells, hyper IgM AID deficiency AICDA AR 605257 XL AD AD AD AD AR AR AD Inheritance TNFSF12 Genetic defect TWEAK deficiency Disease Table 3 (continued) One or more IgG and/or IgA subclasses as well as IgE may be absent IgG and IgA decreased, IgM increased Variable IgG, defects, increased IgM in some, normal B cells, low switched memory B cells, Ig-class switch recombination and somatic hypermutation defects IgG and IgA decreased, IgM increased IgG and IgA decreased, IgM increased Variable immunoglobulin findings Low serum IgG, A and M; low B cell numbers Low IgG, IgA, IgM, low or normal B cells, potentially reducing levels with age Hypogammaglobulenia, absent IgA Normal or low IgG, IgA, IgM, low or normal B cells, low memory B cells B cell deficiency and hypogammaglobulinemia Poor antibody response to pneumococcal vaccine Severe hypogammaglobulinemia, Low IgM and A, lack of anti-pneumococcal antibody Ig May be asymptomatic Family or personal history of cancer Severe bacterial infections Bacterial infections, enlarged lymph nodes and germinal centers Enlarged lymph nodes and germinal centers Recurrent infections, possible autoimmunity and inflammatory disease Hepatopathy, leukopenia, low copper Recurrent sinopulmonary infections Pneumonia, bacterial infections, warts, thrombocytopenia. Neutropenia Bacterial and viral infections, severe neurologic disease, also known as congenital disorder of glycosylation type IIb (CDG-IIb) Congenital sideroblastic anemia, deafness, developmental delay Recurrent bacterial and viral infections, abnormal hair findings: trichorrhexis nodosa Recurrent sinopulmonary infections, COPD, EBV proliferation, autoimmune cytopenias, alopecia and autoimmune thyroiditis Recurrent sinopulmonary infections, alopecia, and endorinopathies Associated features 108 J Clin Immunol (2018) 38:96–128 ? ? ? ? Unknown Unknown Unknown Unknown CARD11 Unknown IgG subclass deficiency with IgA deficiency Selective IgA deficiency Specific antibody deficiency with normal Ig levels and normal B cells Transient hypogammaglobulinemia of infancy CARD11 GOF Selective IgM deficiency 607210 147200 OMIM High B cell numbers due to constitutive NF-κB activation Absent serum IgM IgG and IgA decreased Reduced IgA with decrease in one or more IgG subclass Very low to absent IgA with other isotypes normal, normal subclasses and specific antibodies Normal All immunoglobulins have lambda light chain Reduction in one or more IgG subclass Ig Normal ability to produce antibodies to vaccine antigens, usually not associated with significant infections Splenomegaly, lymphadenopathy, poor vaccine response Pneumococcal / bacterial infections Reduced ability to produce antibodies to specific antigens Bacterial infections, autoimmunity mildly increased Recurrent bacterial infections Usually asymptomatic, a minority may have poor antibody response to specific antigens and recurrent viral/bacterial infections Asymptomatic Associated features EBV Epstein-Barr virus, COPD chronic obstructive pulmonary disease, XL X-linked inheritance, AR autosomal recessive inheritance, AD autosomal dominant inheritance, LOF loss-of-function, GOF gainof-function Common variable immunodeficiency disorders (CVID) include several clinical and laboratory phenotypes that may be caused by distinct genetic and/or environmental factors. Some patients with CVID and no known genetic defect have markedly reduced numbers of B cells as well as hypogammaglobulinemia. Identification of causal variants can assist in defining treatment. In addition to monogenic causes on this table, a small minority of patients with XLP (Table 4), WHIM syndrome (Table 6), ICF (Table 2), VOD1 (Table 2), thymoma with immunodeficiency (Good syndrome) or myelodysplasia are first seen by an immunologist because of recurrent infections, hypogammaglobulinemia and normal or reduced numbers of B cells. Total number of disorders in Table 3: 40. New disorders: 7, PTEN, NFKB1, IKZF1, IRF2BP2, ATP6AP1. Selective igA deficiency, selective IgM deficiency ? AD GOF ? Unknown Isolated IgG subclass deficiency AR Inheritance IGKC Genetic defect Kappa chain deficiency Disease Table 3 (continued) J Clin Immunol (2018) 38:96–128 109 STXBP2 FAAP24 STXBP2/Munc18-2 deficiency (FHL5) FAAP24 deficiency AP3B1 AP3D1 Hermansky-Pudlak syndrome, type 2 Hermansky-Pudlak syndrome, type 10 IL2RA CTLA4 CD25 deficiency CTLA4 deficiency (ALPSV) 3. Regulatory T cell defects FOXP3 IPEX, immune dysregulation, polyendocrinopathy, enteropathy X-linked 603868 RAB27A Griscelli syndrome, type 2 AD AR XL AR AR 123890 147730 300292 617050 603401 606897 2. FHL syndromes with hypopigmentation Chediak-Higashi LYST AR syndrome AR 610884 601717 605014 AR AR or AD AR Decreased Normal to decreased Normal Normal Normal Normal Increased activated T cells Increased activated T cells Increased activated T cells Increased activated T cells STX11 608897 Syntaxin 11 deficiency (FHL4) AR Increased activated T cells Circulating T cells UNC13D OMIM UNC13D/Munc13-4 deficiency (FHL3) Inheritance Increased activated T cells Genetic defect Diseases of immune dysregulation 1. Familial hemophagocytic lymphohistiocytosis (FHL syndromes) Perforin deficiency PRF1 AR 170280 (FHL2) Disease Table 4 Decreased Normal Normal Normal Normal Normal Normal Normal Normal Normal Normal Normal Circulating B cells No CD4 + C25+ cells with impaired function of Tregs cells Impaired function of Tregs. Lack of (and/or impaired function of) CD4+ CD25+ FOXP3+ regulatory T cells (Tregs) Decreased NK and CTL activities (cytotoxicity and/or degranulation) Decreased NK and CTL activities (cytotoxicity and/or degranulation) Decreased NK and CTL activities (cytotoxicity and/or degranulation) Decreased NK and CTL activities (cytotoxicity and/or degranulation) Decreased to absent NK and CTL activities (cytotoxicity and/or degranulation) Decreased NK activity (cytotoxicity and/or degranulation) Decreased NK and CTL activities (cytotoxicity and/or degranulation) Failure to kill autologous EBV transformed B cells. Normal NK cell function Decreased to absent NK and CTL activities cytotoxicity Functional defect Autoimmune cytopenias, enteropathy, interstitial lung disease, Lymphoproliferation, autoimmunity, impaired T cell proliferation Autoimmune enteropathy, early-onset diabetes, thyroiditis hemolytic anemia, thrombocytopenia, eczema, elevated IgE, IgA Partial albinism, recurrent infections, pulmonary fibrosis, increased bleeding, neutropenia, HLH Oculocutaneous albinism, severe neutropenia, recurrent infections, seizures, hearing loss, and neurodevelopmental delay Partial albinism, recurrent infections, fever, HSM, HLH, giant lysosomes, neutropenia, cytopenias, bleeding tendency, progressive neurological dysfunction Partial albinism, fever, HSM, HLH, cytopenias EBV infection-driven lymphoproliferative disease Fever, (H)SM, cHLH, cytopenias, enteropathy Fever, (H)SM, cHLH, cytopenias, Fever, (H)SM, HLH, cytopenias, Fever, (H)SM, hemophagocytic lymphohistiocytosis (HLH), cytopenias Associated features 110 J Clin Immunol (2018) 38:96–128 LRBA STAT3 BACH2 LRBA deficiency STAT3 GOF mutation BACH2 deficiency AD AD (GOF) AR Inheritance AR 613230 147795 190470 176947 606409 607358 605394 102582 606453 OMIM Normal Not assessed Decreased CD8, normal or decreased CD4 cells Decreased Not assessed Normal Progressive T cell lymphopenia Decreased Normal or decreased CD4 numbers, T cell dysregulation Circulating T cells 5. Autoimmune lymphoproliferative syndrome (ALPS, Canale-Smith syndrome) PEPD Prolidase deficiency AD GOF AR TPP2 JAK1 AR (LOF/GOF) ZAP70 ZAP-70 combined hypomorphic and activation mutations Tripeptidyl-peptidase II deficiency JAK1 GOF AR ITCH ITCH deficiency 4. Autoimmunity with or without Lymphoproliferation APECED (APS-1), AIRE AR or AD autoimmune polyendocrinopathy with candidiasis and ectodermal dystrophy Genetic defect Disease Table 4 (continued) Normal Not assessed Peptidase D Hyperactive JAK1 TPP2 deficiency results in premature immunosenescence and immune dysregulation Hyperactive Zap70 kinase Normal or decreased Decreased Itch deficiency may cause immune dysregulation by affecting both anergy induction in autoreactive effector T cells and generation of Tregs AIRE serves as check-point in the thymus for negative selection of autoreactive T cells and for generation of Tregs Enhanced STAT3 signaling, leading to increased Th17 cell differentiation, lymphoproliferation and autoimmunity. Decreased Tregs and impaired function Haplosufficiency for a critical lineage specification transcription factor Reduced I IgG and IgA in most Functional defect Not assessed Normal Impaired memory B cell development Decreased Low or normal numbers of B cells Circulating B cells Variable lymphoproliferation, severe autoimmune cytopenias, hypergammaglobulinemia, recurrent infections HSM, eosinophilia, eosinophilic enteritis, thyroid disease, poor growth, viral infections Autoantibodies common, chronic skin ulcers, eczema, infections Autoimmunity: hypoparathyroidism hypothyroidism, adrenal insufficiency, diabetes, gonadal dysfunction and other endocrine abnormalities, chronic mucocutaneous candidiasis, dental enamel hypoplasia, alopecia areata enteropathy, pernicious anemia Early-onset chronic lung disease (interstitial pneumonitis), autoimmunity (thyroiditis, type I diabetes, chronic diarrhea/enteropathy, and hepatitis), failure to thrive, developmental delay, dysmorphic facial features Severe autoimmunity Lymphocytic colitis, sinopulmonary infections Recurrent infections, inflammatory bowel disease, autoimmunity, EBV infections Lymphoproliferation, solid organ autoimmunity, recurrent infections extra-lymphoid lymphocytic infiltration recurrent infections Associated features J Clin Immunol (2018) 38:96–128 111 TNFRSF6 FASLG CASP10 CASP8 FADD ALPS-FAS ALPS-FASLG ALPS-caspase 10 ALPS-caspase 8 FADD deficiency CD27 CD27 deficiency AR XL 615122 300079 Normal or Increased activated T cells; low/normal iNKT cells Normal XIAP XIAP deficiency (XLP2) 300490 Normal or increased activated T cells XL SH2D1A SH2D1A deficiency (XLP1) Normal Normal AR 146933 Normal Increased DN T cells Slightly increased DN T cells Increased DN T cells Increased DN T cells Increased CD4−CD8−TCR α/β-double negative (DN) T cells Circulating T cells NFAT5 NFAT5 AD 604708 haploinsufficiency 7. Susceptibility to EBV and lymphoproliferative conditions IL10RB IL-10Rb deficiency AR 124092 602457 601763 601762 134638 134637 OMIM Normal IL10RA IL-10Ra deficiency AR AR AR AD AR AD or AR Inheritance 123889 IL10 IL-10 deficiency 6. Immune dysregulation with colitis Genetic defect Disease Table 4 (continued) Increased T cells susceptibility to apoptosis to CD95 and enhanced activation-induced cell death (AICD) Low immunoglobulin after EBV infection Normal or reduced memory B cells No memory B cells normal NK cell and CTL cytotoxic activity Leukocytes unresponsive to IL-10 Leukocytes unresponsive to IL-10, IL-22, IL-26, IL-28A, IL-28B, and IL-29 Decreased memory B cells and plasmablasts No functional IL-10 secretion Defective lymphocyte apoptosis Defective lymphocyte apoptosis and activation Defective lymphocyte apoptosis Reduced memory B cells Normal Normal Normal Normal Normal Normal Normal Apoptosis defect FAS mediated Apoptosis defect FAS mediated Normal, low memory B cells Normal Functional defect Circulating B cells Clinical and immunologic features triggered by EBV infection: HLH, lymphoproliferation, aplastic anemia, lymphoma. hypogammaglobulinemia, absent iNKT cells EBV infection, splenomegaly, lymphoproliferation HLH, colitis, IBD, hepatitis low iNKT cells, hypogammaglobulinemia Features triggered by EBV infection, HLH, aplastic anemia, low iNKT cells, lymphoma IBD, recurrent sinopulmonary infections IBD, Folliculitis, recurrent respiratory diseases, arthritis, lymphoma IBD, folliculitis, recurrent respiratory diseases, arthritis, lymphoma Inflammatory bowel disease (IBD), Folliculitis, recurrent respiratory diseases, arthritis, Functional hyposplenism, bacterial and viral infections, recurrent episodes of encephalopathy and liver dysfunction Adenopathies, splenomegaly, bacterial and viral infections, hypogammaglobulinemia Splenomegaly, adenopathies, autoimmune cytopenias, increased lymphoma risk, IgG and A normal or increased, elevated serum FasL and IL-10, vitamin B12 Splenomegaly, adenopathies, autoimmune cytopenias, SLE, soluble FasL is not elevated Adenopathies, splenomegaly, autoimmunity Associated features 112 J Clin Immunol (2018) 38:96–128 CTPS1 RASGRP1 CD70 (TNFSF7) RLTPR ITK MAGT1 PRKCD CTPS1 deficiency RASGRP1 deficiency CD70 deficiency RLTPR (CARMIL2) deficiency ITK deficiency MAGT1 deficiency (XMEN) PRKCD deficiency AR XL AR AR AR AR AR Inheritance 176977 300853 186973 610859 602840 603962 615897 OMIM Low CD4 Low recent thymic emigrant cells, poor proliferation to CD3 Normal Progressive decrease Nl number, low Treg, poor activation and function Nl number, low Treg, high CD4, poor function Poor activation, proliferation, motility Nl to low, poor proliferation to antigen Circulating T cells Apoptotic defect in B cells Normal Normal Low memory B cells, high CD5 B cells Nl to low Reduced IgM, IgG, IgA (75%) and reduced Ag-specific Ab responses (50%) Nl to low, poor T dependent antibody response Normal IgM, IgG, increased IgA Nl/high IgG Functional defect Normal Poor activation, proliferation, motility Nl number, poor antibody and memory responses Nl number Nl/low Circulating B cells Recurrent infections, EBV chronic infection, lymphoproliferation, SLE-like autoimmunity (nephrotic and antiphospholipid syndromes), low IgG Recurrent bacterial, fungal and mycobacterial infections, viral warts, molluscum and EBV lymphoproliferative and other malignancy, atopy EBV associated B cell lymphoproliferation, lymphoma, Nl or low IgG EBV infection, lymphoma, viral infections, respiratory and GI infections EBV susceptibility, Hodgkin lymphoma Recurrent/chronic bacterial and viral infections (EBV, VZV), lymphoproliferation, B cell non-Hodgkin lymphoma Recurrent pneumonia, herpesvirus infections, EBV associated lymphoma Associated features FHL familial hemophagocytic lymphohistiocytosis, HLH hemophagocytic lymphohistiocytosis, HSM hepatosplenomegaly ((H)SM indicating variable hepatomegaly), DN double negative, SLE systemic lupus erythematous, IBD inflammatory bowel disease, XL X-linked inheritance, AR autosomal recessive inheritance, AD autosomal dominant inheritance, LOF loss-of-function, GOF gain-of-function Total number of disorders in Table 4: 40. New disorders: 9, FAAP24, RASGRP1, CD70, RLTPR, ZAP70 (GOF + LOF), AP3D1, BACH2, JAK1 GOF, PEPD. Removed gene: Hermansky-Pudlak syndrome type 9 was removed due to retraction of the defining publication Genetic defect Disease Table 4 (continued) J Clin Immunol (2018) 38:96–128 113 CSF3R SMARCD2 G-CSF receptor deficiency SMARCD2 deficiency β actin deficiency Leukocyte adhesion deficiency type 3 (LAD3) Rac 2 deficiency HYOU1 deficiency 2. Defects of motility Leukocyte adhesion deficiency type 1 (LAD1) Leukocyte adhesion deficiency type 2 (LAD2) AR AR JAGN1 CLPB ACTB FPR1 AD AR AD RAC2 AR SLC35C1 AR AR ITGB2 FERMT3 AR HYOU1 AR AR AR USB1 AR AR LAMTOR2 VPS13B XL WAS XL AR G6PT1 TAZ AR AR G6PC3 VPS45 AR HAX1 Clericuzio syndrome (poikiloderma with neutropenia) JAGN1 deficiency 3-Methylglutaconic aciduria Barth syndrome (3-methylglutaconic aciduria type II) Cohen syndrome VPS45 deficiency (SCN5) Glycogen storage disease type 1b X-linked neutropenia/ myelodysplasia WAS GOF P14/LAMTOR2 deficiency AD AD Inheritance GFI1 ELANE 1. Congenital neutropenias Elastase deficiency (SCN1) GFI 1 deficiency (SCN2) HAX1 deficiency (Kostmann disease) (SCN3) G6PC3 deficiency (SCN4) Genetic defect Congenital defects of phagocyte number or function Disease Table 5 102630 136537 602049 607901 605881 600065 601746 138971 601736 616012 616254 613276 607817 300394 610389 300392 602671 610035 611045 605998 600871 130130 OMIM N+M N N N + M + L + NK N+M N + M +L + NK N N N N N N N N + L Mel N+M N N+M N N N N N Affected cells Mental retardation, short stature Periodontitis only Poor wound healing, leukocytosis Adherence, chemotaxis O2− production Motility Formylpeptide induced chemotaxis Adherence, chemotaxis Delayed cord separation, skin ulcers, periodontitis, leukocytosis Mild LAD type 1 features with hh-blood group, growth retardation, developmental delay LAD type 1 plus bleeding tendency Neutropenia, developmental aberrations, skeletal abnormalities, hematopoietic stem cells, myelodysplasia Hypoglycemia, inflammatory complications Myeloid maturation arrest, osteopenia Neurocognitive developmental aberrations, microcephaly, hypoglycemia, hypotonia, ataxia, seizures, cataracts, IUGR Dysmorphism, mental retardation, obesity, deafness, neutropenia Retinopathy, developmental delay, facial dysmorphisms, poikiloderma Cognitive and neurological defects in patients with defects in both HAX1 isoforms, susceptibility to MDS/leukemia Structural heart defects, urogenital abnormalities, inner ear deafness, and venous angiectasias of trunks and limbs Extramedullary hematopoiesis, bone marrow fibrosis, nephromegaly Fasting hypoglycemia, lactic acidosis, hyperlipidemia, hepatomegaly Neutropenia, myeloid maturation arrest, monocytopenia, variable lymphoid anomalies Neutropenia Hypogammaglobulinemia ↓CD8 cytotoxicity, partial albinism, growth failure Cardiomyopathy, myopathy, growth retardation, neutropenia Susceptibility to MDS/leukemia Severe congenital neutropenia or cyclic neutropenia B/T lymphopenia Associated features Adherence, chemotaxis, endocytosis, T/NK cytotoxicity Rolling, chemotaxis Stress granulopoiesis disturbed Chromatin remodeling, myeloid differentiation and neutrophil functional defect Unfolded protein response Myeloid differentiation Myeloid differentiation Mitochondrial protein Myeloid differentiation Myeloid differentiation Mitochondrial function Endosomal biogenesis Myeloid differentiation, migration Myeloid differentiation, chemotaxis, O2− production Differentiation, mitosis Myeloid differentiation, chemotaxis, O2− production Myeloid differentiation Myeloid differentiation Myeloid differentiation Affected function 114 J Clin Immunol (2018) 38:96–128 CFTR Cystic fibrosis AR AR AR XL AD NCF1 NCF2 NCF4 G6PD GATA2: loss of stem cells XL (pseudoautosomal) AR CYBA CSF2RA XL CYBB AR AR MKL1 CSF2RB AR DNAJC21 306250 138981 137295 305900 601488 608515 608,512 608508 300481 606078 617048 602421 604734 189965 607444 602365 OMIM Alveolar macrophages Alveolar macrophages Monocytes + peripheral DC N N+M N+M N+M N+M N+M N + M +L + NK N M only N N N N+M Affected cells Infections, autoinflammatory phenotype Infections, autoinflammatory phenotype Infections Killing (faulty O2− production) Killing (faulty O2− production) Reduced O2− production GM-CSF signaling GM-CSF signaling Multi lineage cytopenias Alveolar proteinosis Susceptibility to mycobacteria, HPV, histoplasmosis, alveolar proteinosis, MDS/AML/CMMoL, lymphedema Alveolar proteinosis Infections, autoinflammatory phenotype Killing (faulty O2− production) Killing (faulty O2− production) Infections, autoinflammatory phenotype, IBD McLeod phenotype in patients with deletions extending into the contiguous Kell locus Infections, autoinflammatory phenotype Periodontitis, palmoplantar hyperkeratosis in some patients Neutrophils with bilobed nuclei Pancytopenia, exocrine pancreatic insufficiency, chondrodysplasia Mild neutropenia, poor wound healing, severe stomatitis, neutrophil nuclei herniate Respiratory infections, pancreatic insufficiency, elevated sweat chloride Metaphyseal changes, short stature, developmental delay, pancreatic dysfunction, bone marrow failure Mild thrombocytopenia Associated features Killing (faulty O2− production) Impaired expression of cytoskeletal genes Motility, ribosome biogenesis Chemotaxis Spreading, survival, chemotaxis Chemotaxis Chemotaxis Chemotaxis Affected function MDS myelodysplastic syndrome, IUGR intrauterine growth retardation, LAD leukocyte adhesion deficiency, AML acute myelogenous leukemia, CMML chronic myelomonocytic leukemia, N neutrophil, M monocyte, MEL melanocyte, L lymphocyte, NK natural killer, XL X-linked inheritance, AR autosomal recessive inheritance, AD autosomal dominant inheritance, GOF gain-of-function Total number of disorders in Table 5: 39. New disorders: 9, WDR1, CFTR, SMARCD2, JAGN1, HYOU1, MKL1, DNAJC21, G6PD, CSF2RB. Removed: cyclic neutropenia was merged with elastase deficiency Congenital pulmonary alveolar proteinosis due to CSF2RB mutations Congenital pulmonary alveolar proteinosis due to CSF2RA mutations Schwachman Diamond syndrome due to DNAJC21 deficiency Neutropenia with combined immune deficiency due to MKL1 deficiency 3. Defects of respiratory burst X-linked chronic granulomatous disease (CGD), gp91phox Autosomal recessive CGD p22phox Autosomal recessive CGD p47phox Autosomal recessive CGD p67phox Autosomal recessive CGD p40phox G6PD deficiency class I 4. Other non-lymphoid defects GATA2 deficiency (MonoMac syndrome) AR WDR1 AR AR AR AR Inheritance CEBPE SBDS CTSC Genetic defect Specific granule deficiency Shwachman-Diamond syndrome WDR1 deficiency Localized juvenile periodontitis Papillon-Lefèvre syndrome Disease Table 5 (continued) J Clin Immunol (2018) 38:96–128 115 Genetic defect Defects in intrinsic and innate immunity Inheritance AD CYBB IRF8 IRF8 TYK2 ISG15 RORC JAK1 Macrophage gp91 phox deficiency IRF8 deficiency (AD) IRF8 deficiency (AR) Tyk2 deficiency ISG15 deficiency RORc deficiency JAK1 (LOF) AR AD GOF TMC6 TMC8 CXCR4 EVER2 deficiency WHIM (warts, hypogammaglobulinemia, infections, myelokathexis) syndrome AR AR AR AR AR AR AD EVER1 deficiency 2. Epidermodysplasia verruciformis (HPV) XL STAT1 STAT1 deficiency (AD LOF) AR IFNGR2 IFN-γ receptor 2 deficiency AR/AD IFNGR1 IFN-γ receptor 1 deficiency 1. Mendelian susceptibility to mycobacterial disease (MSMD) IL-12 and IL-23 receptor β1 IL12RB1 AR chain deficiency IL-12p40 (IL-12 and IL-23) IL12B AR deficiency Disease Table 6 162643 605829 605828 147795 602943 147571 176941 601565 601565 300481 600555 147569 Granulocytes + lymphocytes Keratinocytes and leukocytes Keratinocytes and leukocytes N+L L + NK Normal, but multiple cytokine signaling defect CD1c+ MDC CD1c+ MDC Macrophage only M+L M+L M+L M 161561 107470 L + NK Affected cells 601604 OMIM EVER proteins may be involved in the regulation of cellular zinc homeostasis in lymphocytes EVER proteins may be involved in the regulation of cellular zinc homeostasis in Ly Increased response of the CXCR4 chemokine receptor to its ligand CXCL12 (SDF-1) Lack of functional RORγT protein, IFNγ production defect, complete absence of IL-17A/F-producing T cells IFNγ production IFNγ production defect Normal Killing (faulty O2− production) Differentiation of CD1c+ MDC subgroup Differentiation of CD1c+ MDC subgroup IFN-γsignaling IFN-γ signaling IFN-γ binding and signaling IFN-γ secretion IFN-γ secretion Affected function Warts, neutropenia, low B cell number, hypogammaglobulinemia HPV (group B1) infections and cancer of the skin (typical EV) Human papillomavirus (HPV) (group B1) infections and cancer of the skin (typical EV) Susceptibility to mycobacteria and viruses, urothelial carcinoma Susceptibility to intracellular bacteria (mycobacteria, Salmonella), viruses, +/− elevated IgE Susceptibility to mycobacteria (BCG), brain calcification Susceptibility to mycobacteria and candida Susceptibility to mycobacteria and multiple other infectious agents Susceptibility to mycobacteria Susceptibility to mycobacteria, Salmonella Isolated susceptibility to mycobacteria Susceptibility to mycobacteria and Salmonella Susceptibility to mycobacteria and Salmonella Susceptibility to mycobacteria and Salmonella Susceptibility to mycobacteria and Salmonella Associated features 116 J Clin Immunol (2018) 38:96–128 Genetic defect AR FCGR3A IFIH1 CD16 deficiency MDA5 deficiency (LOF) IRF3 IRF3 deficiency AD AD IL-17RC deficiency IL17RC AR AR TBK1 TBK1 deficiency AD or AR 6. Predisposition to mucocutaneous candidiasis IL-17RA deficiency IL17RA TICAM1 TRIF deficiency AD AR TRAF3 TRAF3 deficiency AR AD or AR AR 5. Predisposition to invasive fungal diseases CARD9 deficiency CARD9 UNC93B1 UNC93B1 deficiency 4. Herpes simplex encephalitis (HSE) TLR3 deficiency TLR3 AR IFNAR2 IFNAR2 deficiency AR IRF7 IRF7 deficiency AR STAT2 AR Inheritance STAT2 deficiency 3. Predisposition to severe viral infection STAT1 deficiency (AR LOF) STAT1 Disease Table 6 (continued) 610925 605461 607212 616532 604834 607601 601896 608204 603029 606951 146740 602376 605047 600556 600555 OMIM Epithelial cells, fibroblasts, mononuclear phagocytes Epithelial cells, fibroblasts, mononuclear phagocytes Mononuclear phagocytes CNS resident cells and fibroblasts CNS resident cells and fibroblasts CNS resident cells and fibroblasts CNS resident cells and fibroblasts CNS resident cells and fibroblasts Central nervous system (CNS) resident cells and fibroblasts Somatic and hematopoietic NK cells Leukocytes, plasmacytoid dendritic cells, non-hematopoietic cells Broadly expressed T and NK cells and monocytes T and NK cells Affected cells IL-17RC signaling pathway IL-17RA signaling pathway CARD9 signaling pathway UNC-93B-dependent IFN-α, β, and γ response TRAF3-dependent IFN-α, β, and γ response TRIF-dependent IFN-α, β, and γ response TBK1-dependent IFN-α, β, and γ response Low IFN-α/β production in response to HSV1 and decreased IRF3 phosphorylation TLR3-dependent IFN-α, β, and γ response Viral recognition Altered NK cells function No response to IFN-α STAT1-dependent IFN-α, β, and γ response STAT2-dependent IFN-α, β, and γ response IFN-α, β, and γ production and IFN-λ production Affected function CMC CMC, folliculitis Invasive candidiasis infection, deep dermatophytoses, other invasive fungal infections Herpes simplex virus 1 encephalitis Herpes simplex virus 1 encephalitis Herpes simplex virus 1 encephalitis Herpes simplex virus 1 encephalitis Herpes simplex virus 1 encephalitis (incomplete clinical penetrance for all etiologies listed here) Herpes simplex virus 1 encephalitis Severe viral infections (disseminated vaccine-strain measles, HHV6) Severe herpes viral infections, particularly VZV, Epstein-Barr virus (EBV), and (HPV) Rhinovirus and other RNA viruses Severe viral infections, mycobacterial infection Severe viral infections (disseminated vaccine-strain measles) Severe influenza disease Associated features J Clin Immunol (2018) 38:96–128 117 TRAF3IP2 ACT1 deficiency AR AD AD GOF Inheritance IRAK1 TIRAP IRAK1 deficiency TIRAP deficiency AR XL AR Isolated congenital asplenia (ICA) due to HMOX deficiency Trypanosomiasis Acute liver failure due to NBAS deficiency Acute necrotizing encephalopathy CLCN7 deficiency associated osteopetrosis SNX10 deficiency associated osteopetrosis AR AD AR AD AR AR HMOX APOL1 NBAS RANBP2 CLCN7 SNX10 8. Other inborn errors of immunity related to non-hematopoietic tissues RPSA AD Isolated congenital asplenia (ICA) due to RPSA deficiency MYD88 MyD88 deficiency 7. TLR signaling pathway deficiency with bacterial susceptibility IRAK-4 deficiency IRAK4 AR IL17F STAT1 Genetic defect IL-17F deficiency STAT1 GOF Disease Table 6 (continued) 614780 602727 601181 603743 608025 141250 271400 614382 Not yet attributed 602170 606883 607043 606496 600555 OMIM Osteoclasts Osteoclasts Ubiquitous expression Somatic Somatic and hematopoietic Macrophages No spleen Lymphocytes + granulocytes+ monocytes Lymphocytes + granulocytes + monocytes Lymphocytes + granulocytes + monocytes Lymphocytes + granulocytes + monocytes T cells, fibroblasts T cells T cells, B cells, monocytes Affected cells Bacterial infections, X-linked MECP2 deficiency-related syndrome due to a large de novo Xq28 chromosomal deletion encompassing both MECP2 and IRAK1 Staphylococcal disease during childhood TIR-IRAK1 signaling pathway Secretory lysosomes Secretory lysosomes Nuclear pore RPSA encodes ribosomal protein SA, a component of the small subunit of the ribosome HO-1 regulates iron recycling and heme-dependent damage occurs Lipid ER stress Osteopetrosis with hypocalcemia, neurologic features Osteopetrosis with visual impairment Fever induces acute encephalopathy Trypanosomiasis Fever induces liver failure Hemolysis, nephritis, inflammation Bacteremia (encapsulated bacteria) Bacterial infections (pyogens) TIR-MyD88 signaling pathway TIRAP- signaling pathway, TLR1/2, TLR2/6, and TLR4 agonists were impaired in the fibroblasts and leukocytes Bacterial infections (pyogens) CMC, blepharitis, folliculitis and macroglossia CMC, folliculitis CMC, various fungal, bacterial and viral (HSV) infections, autoimmunity (thyroiditis, diabetes, cytopenias), enteropathy Associated features TIR-IRAK4 signaling pathway IL-17F-containing dimers Gain-of-function STAT1 mutations that impair the development of IL-17-producing T cells Fibroblasts fail to respond to IL-17A and IL-17F, and their T cells to IL-17E Affected function 118 J Clin Immunol (2018) 38:96–128 AR AR AR TCIRG1 TNFRSF11A TNFSF11 PSENEN PSENEN deficiency hidradenitis suppurativa AD AD 607632 104311 605254 602642 603499 604592 611466 607649 OMIM Epidermis Epidermis Epidermis Stromal Osteoclasts Osteoclasts Osteoclasts Osteoclasts Affected cells Gamma-secretase in hair follicle regulates keratinization Gamma-secretase in hair follicle regulates keratinization Gamma-secretase in hair follicle regulates keratinization Osteoclastogenesis Osteoclastogenesis Secretory lysosomes Secretory lysosomes Secretory lysosomes Affected function Hidradenitis suppurativa Hidradenitis suppurative with cutaneous hyperpigmentation Hidradenitis suppurativa with acne Osteopetrosis with severe growth retardation Osteopetrosis Osteopetrosis with hypocalcemia Osteopetrosis with hypocalcemia, neurologic features Osteopetrosis Associated features NF-κB nuclear factor kappa B, TIR Toll and interleukin-1 receptor, IFN interferon, TLR Toll-like receptor, MDC myeloid dendritic cell, CNS central nervous system, CMC chronic mucocutaneous candidiasis, HPV human papillomavirus, VZV varicella zoster virus, EBV Epstein-Barr virus, HHV6 human herpesvirus 6, XL X-linked inheritance, AR autosomal recessive inheritance, AD autosomal dominant inheritance, LOF loss-of-function, GOF gain-of-function Total number of disorders in Table 6: 52. New genes: 19, IFNAR2, IRF3, JAK1, IRAK1, TIRAP, IFIH1, HMOX, NBAS, RANBP2, CLCN7, SNX10, OSTM1, PLEKHM1, TCIRG1, TNFRSF11A, TNFSF11, NCSTN, PSEN, PSENEN PSEN AD AR PLEKHM1 NCSTN AR Inheritance OSTM1 Genetic defect PSEN deficiency hidradenitis suppurativa NCSTN deficiency hidradenitis suppurativa OSTM1 deficiency associated osteopetrosis PLEKHM1 deficiency associated osteopetrosis TCIRG1 deficiency associated osteopetrosis TNFRSF11A deficiency associated osteopetrosis TNFSF11 deficiency associated osteopetrosis Disease Table 6 (continued) J Clin Immunol (2018) 38:96–128 119 AR AD AR RNASEH2B RNASEH2C RNASEH2A SAMHD1 ADAR1 IFIH1 (GOF) ACP5 TMEM173 POLA1 USP18 RNASEH2B deficiency, AGS2 RNASEH2C deficiency, AGS3 RNASEH2A deficiency, AGS4 SAMHD1 deficiency, AGS5 ADAR1 deficiency, AGS6 Aicardi-Goutieres syndrome 7 (AGS7) Spondyloenchondro-dysplasia with immune dysregulation (SPENCD) STING-associated vasculopathy, infantile-onset X-linked reticulate pigmentary disorder USP18 deficiency AR XL AR AR AR AR AR Inheritance AR or AD Autoinflammatory disorders 1. Type 1 interferonopathies Disease Genetic defect TREX1 deficiency, TREX1 Aicardi-Goutieres syndrome 1 (AGS1) Table 7 607057 301220 612374 171640 606951 146920 606754 606034 610330 610326 OMIM 606609 Not assessed Not assessed Not assessed Not assessed Not assessed Not assessed Not assessed Not assessed Not assessed Not assessed T cells Not assessed Not assessed Not assessed Not assessed Not assessed Not assessed Not assessed Not assessed Not assessed Not assessed Not assessed B cells Not assessed Classical AGS, SLE, SP, SMS Classical AGS, BSN, SP Classical AGS, FCL Classical AGS Classical AGS Classical AGS, SP Associated features Classical AGS, SLE, FCL Short stature, SP, ICC, SLE, thrombocytopenia and autoimmune hemolytic anemia, possibly recurrent bacterial and viral infections Skin vasculopathy, STING activates both the inflammatory lung NF-kappa-B and IRF3 disease, systemic transcription pathways to autoinflammation and induce expression of IFN ICC, FCL POLA1 is required for synthesis Hyperpigmentation, characteristic facies, lung of cytosolic RNA:DNA and and GI involvement its deficiency leads to increase production of type I interferon TORCH like syndrome Functional defect Intracellular accumulation of abnormal ss DNA species leading to increased type I IFN production Intracellular accumulation of abnormal RNA-DNA hybrid species leading to increased type I IFN production Intracellular accumulation of abnormal RNA-DNA hybrid species leading to increased type I IFN production Intracellular accumulation of abnormal RNA-DNA hybrid species leading to increased type I IFN production Controls dNTPs in the cytosol, failure of which leads to increased type I IFN production Catalyzes the deamination of adenosine to inosine in dsRNA substrates, failure of which leads to increased type I IFN production IFIH1 gene encodes a cytoplasmic viral RNA receptor that activates type I interferon signaling through the MAVS adaptor molecule Upregulation of IFN through mechanism possibly relating to pDCS 120 J Clin Immunol (2018) 38:96–128 AD DDX58 Familial cold autoinflammatory syndrome 1 Familial cold autoinflammatory syndrome 2 Neonatal onset multisystem inflammatory disease (NOMID) or chronic infantile neurologic cutaneous and articular syndrome (CINCA) NLRC4-MAS (macrophage activating syndrome) or familial cold autoinflammatory syndrome 4 PLAID (PLCγ2 associated antibody deficiency and immune dysregulation) or familial cold Mevalonate kinase deficiency (Hyper IgD syndrome) Muckle-Wells syndrome AD GOF AD GOF AD GOF AD GOF AD GOF NLRP12 NLRP3 NLRC4 PLCG2 AD GOF NLRP3 (also called NALP3 CIAS1 or PYPAF1) NLRP3 AR MVK Inheritance AR or AD AR and AD PSMB8a 2. Defects affecting the inflammasome Disease Genetic defect Familial Mediterranean MEFV fever CANDLE (chronic atypical neutrophilic dermatitis with lipodystrophy) Singleton-Merten syndrome Table 7 (continued) 614468 616050 616115 607115 611762 120100 191900 260920 OMIM 249100 134610 609631 256040 B cells, NK, mast cells PMNs monocytes macrophages PMNs, chondrocytes PMNs, monocytes PMNs, monocytes PMNs Monocytes Somatic and hemaotpoietic Affected cells Mature granulocytes, cytokine-activated monocytes Not assessed Not assessed Mutations cause activation of IL-1 pathways Gain-of-function mutation in NLRC4 results in elevated secretion of IL-1β and IL-18 as well as macrophage activation As above As above Functional defects Decreased production of pyrin permits ASC-induced IL-1 processing and inflammation following subclinical serosal injury, macrophage apoptosis decreased Affecting cholesterol synthesis, pathogenesis of disease unclear Defect in cryopyrin, involved in leukocyte apoptosis and NFkB signaling and IL-1 processing As above Not assessed Not assessed Cold urticaria hypogammaglobulinemia, autoinflammation Severe enterocolitis and macrophage activation syndrome Non-pruritic urticaria, arthritis, chills, fever and leukocytosis after cold exposure Non-pruritic urticaria, arthritis, chills, fever and leukocytosis after cold exposure Neonatal onset rash, chronic meningitis, and arthropathy with fever and inflammation Urticaria, SNHL, amyloidosis Periodic fever and leukocytosis with high IgD levels Associated features Recurrent fever, serositis and inflammation responsive to colchicine. Predisposes to vasculitis and inflammatory bowel disease Recognizes double stranded RNA Dental dysplasia), calcifications in the aorta, osteoporosis, especially in the hands and feet Defective negative regulation of ISG15 leading to increased IFN Mutations cause increased IFN Contractures, panniculitis, signaling through an ICC, fevers undefined mechanism J Clin Immunol (2018) 38:96–128 121 NLRP1 SH3BP2 Cherubism AR SLC29A3 AD AD AR IL36RN CARD14 AR IL1RN CAMPS (CARD14 mediated psoriasis) AR LPIN2 Chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anemia (Majeed syndrome) DIRA (deficiency of the interleukin-1 receptor antagonist) DITRA (deficiency of IL-36 receptor antagonist) SLC29A3 mutation AR AD NOD2 (also called CARD15) ADAM17 AD PSTPIP1 (also called C2BP1) Inheritance AD AR ADAM17 deficiency Pyogenic sterile arthritis, pyoderma gangrenosum, acne (PAPA) syndrome, hyperzincemia, and hypercalprotectinemia Blau syndrome 3. Non-inflammasome-related conditions Disease Genetic defect TNF receptor-associated TNFRSF1A periodic syndrome (TRAPS) autoinflammatory syndrome 3 or APLAID (c2120A>C) NLRP1 deficiency Table 7 (continued) 118400 602723 602782 614204 612852 609628 614328 186580 604416 OMIM 142680 606579 Undefined Mutations in nucleotide binding site of CARD15, possibly disrupting interactions with lipopolysaccharides and NF-kB signaling Defective TNFα production Functional defects Mutations of 55-kD TNF receptor leading to intracellular receptor retention or diminished soluble cytokine receptor available to bind TNF Disordered actin reorganization leading to compromised physiologic signaling during inflammatory response Stroma cells, bone cells Mainly in keratinocytes Leukocytes, bone cells Mutations in CARD14 activate the NF-kB pathway and production of IL-8 Bone degeneration in jaws Hyperpigmentation hypertrichosis, histiocytosis-lymphadenopathy plus syndrome Psoriasis Neonatal onset of sterile multifocal osteomyelitis, periostitis and pustulosis Pustular psoriasis Early-onset diarrhea and skin lesions Chronic recurrent multifocal osteomyelitis, transfusion-dependent anemia, cutaneous inflammatory disorders Uveitis, granulomatous synovitis, camptodactyly, rash and cranial neuropathies, 30% develop Crohn colitis Destructive arthritis, inflammatory skin rash, myositis Associated Features Recurrent fever, serositis, rash, and ocular or joint inflammation Systemic elevation of IL-18 and Dyskeratosis, autoimmunity and arthritis caspase 1, suggesting involvement of NLRP1 inflammasome Mutations in the IL-1 receptor antagonist allow unopposed action of interleukin-1 Keratinocytes, leukocytes Mutations in IL-36RN leads to increase IL-8 production PMNs, Monocytes Leukocytes and epithelial cells Neutrophils, bone marrow cells Monocytes Hematopoietic tissues, upregulated in activated T cells Affected cells PMNs, monocytes Leukocytes 122 J Clin Immunol (2018) 38:96–128 OTULIN TNFAIP3 CECR1 AP1S3 Otulipenia/ORAS A20 deficiency ADA2 deficiency AP1S3 deficiency AR AR AD LOF AR AD 615781 607575 616744 615712 6011924 Keratinocytes Lymphocytes Lymphocytes Leukocytes PMN and tissue specific cells Hyperactived macrophage and increase NF-kB Defective intracellular transport Autoimmune inflammatory via the coat protein complex I arthritis and interstitial lung (COPI) disease with Th17 dysregulation and autoantibody production Fever, diarrhea, dermatitis Increase LUBAC induction of NF-KB activation leading to high proinflammatory cytokines levels Defective inhibition of NF-KB Arthralgia, mucosal ulcers, signaling pathway ocular inflammation Polyarteritis nodosa, ADAs deactivate extracellular childhood-onset, early-onset adenosine and terminate recurrent ischemic stroke and signaling through adenosine fever receptors Disrupted TLR3 translocation Pustular psoriasis a Variants in PSMB4, PSMB9, PSMA3, and POMP have been proposed to cause a similar CANDLE phenotype in monogenic and digenic models IFN interferon; HSM hepatosplenomegaly; CSF cerebrospinal fluid; SLE systemic lupus erythematosus; TORCH toxoplasmosis, other, rubella, cytomegalovirus, and herpes infections; SNHL sensorineural hearing loss; AGS Aicardi-Goutières syndrome; BSN bilateral striatal necrosis; FCL familial chilblain lupus; ICC intracranial calcification; IFN interferon type I; pDCs plasmacytoid dendritic cells; SP spastic paraparesis; SMS Singleton-Merten syndrome; ss single-stranded DNA; XL X-linked inheritance; AR autosomal recessive inheritance; AD autosomal dominant inheritance; LOF loss-of-function; GOF gain-of-function Total number of disorders in Table 7: 37. New disorders: 7, DDX58, POLA1, USP18, NLRP1, OTULIN, TNFAIP3, AP1S3 COPA COPA defect Table 7 (continued) J Clin Immunol (2018) 38:96–128 123 Complement deficiencies Genetic defect C1QA C1QB C1QC C1R C1S C4A + C4B C2 C3 C3 C5 C6 C7 C8A C8G C8B: C9 MASP2 FCN3 Disease C1q deficiency due to defects in C1QA C1q deficiency due to defects in C1QB C1q deficiency due to defects in C1QC C1r deficiency C1s deficiency Complete C4 deficiency C2 deficiency C3 deficiency (LOF) C3 GOF C5 deficiency C6 deficiency C7 deficiency C8α deficiency C8γ deficiency C8β-deficiency C9 deficiency MASP2 deficiency Ficolin 3 deficiency 1. Complement deficiencies Table 8 AR AR AR AR AR AR AR AR AD AR AR AR AR AR AR AR AR AR Inheritance 604973 605102 120940 120960 120930 120950 217070 217050 120700 120900 120700 217000 120810 120580 613785 120575 120570 120550 Gene OMIM Absence of complement activation by the Ficolin 3 pathway. Deficient activation of the lectin activation pathway Absent CH50 hemolytic activity, defective activation of the classical pathway, complete deficiency requires biallelic mutations/deletions/conversions of both C4A and C4B Absent CH50 hemolytic activity, defective activation of the classical pathway Absent CH50 and AH50 hemolytic activity, defective opsonization, defective humoral immune response Increased activation of complement Absent CH50 and AH50 hemolytic activity Defective bactericidal activity Absent CH50 and AH50 hemolytic activity, defective bactericidal activity Absent CH50 and AH50 hemolytic activity, defective bactericidal activity Absent CH50 and AH50 hemolytic activity, defective bactericidal activity Absent CH50 and AH50 hemolytic activity, defective bactericidal activity Absent CH50 and AH50 hemolytic activity, defective bactericidal activity Reduced CH50 and AP50 hemolytic activity, deficient bactericidal activity Absent CH50 hemolytic activity, defective activation of the classical pathway Absent CH50 hemolytic activity, defective activation of the classical pathway, diminished clearance of apoptotic cells Absent CH50 hemolytic activity, Defective activation of the classical pathway, diminished clearance of apoptotic cells Absent CH50 hemolytic activity, Defective activation of the classical pathway, diminished clearance of apoptotic cells Absent CH50 hemolytic activity, defective activation of the classical pathway Laboratory features Pyogenic infections, inflammatory lung disease, autoimmunity Respiratory infections, abscesses Mild susceptibility to disseminated neisserial infections Disseminated neisserial infections Disseminated neisserial infections Disseminated neisserial infections Disseminated neisserial infections Disseminated neisserial infections SLE, infections with encapsulated organisms, Ehlers-Danlos phenotype SLE, infections with encapsulated organisms, partial deficiency is common (either C4A or C4B) and appears to have a modest effect on host defense SLE, infections with encapsulated organisms, atherosclerosis Infections, glomerulonephritis, atypical hemolytic-uremic syndrome with GOF mutations Atypical hemolytic-uremic syndrome Disseminated neisserial infections SLE, infections with encapsulated organisms, Ehlers-Danlos phenotype SLE, infections with encapsulated organisms SLE, infections with encapsulated organisms SLE, infections with encapsulated organisms Associated features 124 J Clin Immunol (2018) 38:96–128 AD AD AR AR CFB CFB CFD CFP CFI CFH CFHR1-5 THBD CD46 CD59 CD55 Factor B GOF Factor B LOF Factor D deficiency Properdin deficiency Factor I deficiency Factor H deficiency Factor H-related protein deficiencies Thrombomodulin deficiency Membrane cofactor protein (CD46) deficiency Membrane attack Complex inhibitor (CD59) deficiency CD55 deficiency (CHAPEL disease) 125240 107271 120920 188040 134371, 600889, 605336, 605337, 608593 134370 300383 217030 138470 134350 138470 606860 Gene OMIM Inhibitor of complement alternate pathway, decreased C3b binding Erythrocytes highly susceptible to complement-mediated lysis Hyperactivation of complement on endothelium Normal CH50, AH50, autoantibodies to factor H, linked deletions of one or more CFHR genes leads to susceptibility autoantibody-mediated aHUS Normal CH50, AH50 Spontaneous activation of the alternative complement pathway with consumption of C3 Absent AH50 hemolytic activity Spontaneous activation of the alternative complement pathway with consumption of C3 Spontaneous activation of the complement pathway with consumption of C4/C2, spontaneous activation of the contact system with generation of bradykinin from high molecular weight kininogen Gain-of-function mutation with increased spontaneous AH50 Deficient activation of the alternative pathway Absent AH50 hemolytic activity Laboratory features Protein losing enteropathy, thrombosis Atypical hemolytic-uremic syndrome, infections, preeclampsia Hemolytic anemia, polyneuropathy Atypical hemolytic-uremic syndrome Neisserial infections Infections, disseminated neisserial infections, atypical hemolytic-uremic syndrome, preeclampsia Infections, disseminated neisserial infections, atypical hemolytic-uremic syndrome, preeclampsia Older onset atypical hemolytic-uremic syndrome, disseminated neisserial infections Infections with encapsulated organisms Neisserial infections Atypical hemolytic-uremic syndrome Hereditary angioedema Associated features MAC membrane attack complex, SLE systemic lupus erythematosus, XL X-linked inheritance, AR autosomal recessive inheritance, AD autosomal dominant inheritance, LOF loss-of-function, GOF gainof-function Total number of disorders in Table 8: 30. New disorders: 1, CD55 AR or AD AR or AD XL AR AR AR AD AD SERPING1 C1 inhibitor deficiency Inheritance Genetic defect Disease 1. Complement deficiencies Table 8 (continued) J Clin Immunol (2018) 38:96–128 125 Phenocopies of inborn errors of immunity AutoAb to CI inhibitor AutoAb to complement factor H AutoAb to various cytokines Acquired angioedema Atypical hemolytic-uremic syndrome Thymoma with hypogammaglobulinemia (Good syndrome) Normal No B cells Increased CD8+ T cells Normal Normal Normal Normal Normal Normal Normal Normal Decreased naive T cells aHUS atypical hemolytic-uremic syndrome, GOF gain-of-function, PRCA pure red cell aplasia Total number of conditions for Table 9: 12 AutoAb to GM-CSF AutoAb to IL-6 Normal Normal Normal Normal Lymphocytosis B cell lymphocytosis Normal, but increased number of CD5+ B cells Circulating B cells Normal Clonal expansion of large T cells Somatic mutations in STAT3 (GOF) Germline mutation in AIRE AutoAb to IL-17 and/or IL-22 AutoAb to IFNγ Normal Somatic mutation in STAT5b (GOF) Pulmonary alveolar proteinosis Associated with autoantibodies Chronic mucocutaneous candidiasis (isolated or with APECED syndrome) Adult-onset immunodeficiency with susceptibility to mycobacteria Recurrent skin infection Increased CD4−CD8− double negative (DN) T alpha/beta cells Normal Somatic mutation in NRAS (GOF) RAS-associated autoimmune leukoproliferative disease (RALD) Cryopyrinopathy, (Muckle-Wells/CINCA/ NOMID-like syndrome) Hypereosinophilic syndrome due to somatic mutations in STAT5b Large granular lymphocytosis Somatic mutation in NLRP3 Normal Increased CD4−CD8− double negative (DN) T alpha/beta cells Somatic mutation in KRAS (GOF) Somatic mutation in TNFRSF6 Associated with somatic mutations Autoimmune lymphoproliferative syndrome (ALPS–SFAS) Circulating T cells RAS-associated autoimmune leukoproliferative disease (RALD) Genetic defect/presumed pathogenesis Disease 1. Phenocopies of inborn errors of immunity Table 9 Decreased Normal Normal Normal Normal Normal Normal Normal Normal Normal Normal or increased Normal or increased Normal or increased Serum Ig Staphylococcal infections/STAT3 deficiency Pulmonary alveolar proteinosis, cryptococcal meningitis, disseminated nocardiosis/CSF2RA deficiency Angioedema/C1 INH deficiency (hereditary angioedema) aHUS = spontaneous activation of the alternative complement pathway Invasive bacterial, viral or opportunistic infections, autoimmunity, PRCA, lichen planus, cytopenia, colitis, chronic diarrhea Mycobacterial, fungal, Salmonella VZV infections/MSMD, or CID Endocrinopathy, chronic mucocutaneous candidiasis/CMC Anemia, neutropenia, splenomegaly Urticaria-like rash, arthropathy, neurological signs Eosinophilia, atopic dermatitis, urticarial rash, diarrhea Splenomegaly, lymphadenopathy, autoimmune cytopenias, defective lymphocyte apoptosis/ALPS–FAS (=ALPS type Im) Splenomegaly, lymphadenopathy, autoimmune cytopenias, granulocytosis, monocytosis/ ALPS-like Splenomegaly, lymphadenopathy, autoantibodies/ALPS-like Associated features/similar PID 126 J Clin Immunol (2018) 38:96–128 J Clin Immunol (2018) 38:96–128 the phenotype of a given disorder was clear, the spectrum of manifestations often extends impressively once the ascertainment is not linked to a preconceived idea [20]. As a community, we recognize the importance of publishing cases and small series and to report specific mutations with clinical findings because publications are used to define likelihood of causality during bioinformatic analysis of next-generation sequencing results. In 1999, the Committee on Primary Immunodeficiencies came under the auspices of the International Union of Immunological Societies (IUIS). The current committee met on February 23–24, 2017, in London to update the classification of human primary immunodeficiencies. Inclusion in this “master list” requires a body of literature supporting causality of a gene defect and a penetrance indicating clinical relevance [21]. Committee members vote on inclusion of each new disorder and this publications lists those included as of the February 2017 meeting. The landscape is changing so rapidly, and the number of primary immunodeficiencies growing so fast, that two major changes have been implemented. The published list will continue to serve as a reference; however, this list will now be available as a csv file on the IUIS website to enable sorting according to gene, disease name, or clinical/ laboratory feature. This file will also include the associated ICD10 codes in order to promote harmonization of utilization. The second major change is to the nomenclature. The term primary immunodeficiency has an important legacy—the abbreviations PID or PIDD are often used by patient organizations and are recognized around the world. However, this terminology does limit the conceptualization of disorders to those in which susceptibility to infection is the main manifestation. The improving recognition of immune dysregulation diseases, including the growing field of autoinflammatory disorders and interferonopathies, has mandated that a more encompassing terminology be used. This manuscript, therefore, utilizes “inborn errors of immunity” as the descriptor for the work and the categorization. In addition to embracing technology to remain updated, the companion publication “Update of the Phenotypical IUIS Classification for Primary Immunodeficiencies” will provide a phenotype-oriented approach to the IUIS categorization of disorders. Moreover, a new free application can be found as “PID phenotypical diagnosis” or “PID classification” from iTunes and Android app stores [22, 23]. Information that is readily accessible is the new standard, and the IUIS Expert Committee on Primary Immunodeficiencies believes that improved access to information will positively impact patient care around the world. The tables divide disease categories according to common phenotypes for ease of review and searching. Table 1 lists combined immunodeficiencies, Table 2 lists combined immunodeficiencies with syndromic features, Table 3 lists predominantly antibody deficiencies, Table 4 lists diseases of immune dysregulation, Table 5 127 lists defects of phagocyte number or function, Table 6 lists defects in intrinsic and innate immunity, Table 7 lists autoinflammatory diseases, Table 8 lists complement deficiencies, and Table 9 lists phenocopies of inborn errors of immunity. The division into phenotypes for the purpose of this list does not imply that the presentation is homogeneous. Each disorder is listed only once for the sake of simplicity although distinct modes of inheritance can be listed separately. There are nine genes for which both loss-of-function and gain-of-function variants have been identified: CFB, C3, CARD11, STAT1, STAT3, WAS, JAK1, IFIH1, and ZAP70. For these, the loss-of-function and gain-of-function aspects are listed. Within each table, there are additional sub-tables that segregate into coherent phenotypic sets. At the end of each table, the new disorders, added for this publication, are listed for easy reference. Other features important for navigation of the list include the use of OMIM links [24]. For additional information on a gene, the links can be accessed from within the online publication. For the second time, we also include non-inborn errors of immunity in Table 9, representing phenocopies of inborn errors which might be important to consider diagnostically. The goal of the IUIS Expert Committee on Primary Immunodeficiencies is to increase awareness, facilitate recognition, promote optimal treatment, and support research in the field of immune deficiency disorders. Thus, the “IUIS PID Committee Report on Inborn Errors of Immunity” and “Update of the Phenotypical IUIS Classification for Primary Immunodeficiencies” publications are important resources for clinicians and researchers. In addition, these tables form the basis of lists used for sequencing panels and are used to monitor health utilization which will influence health services funding by federal or state governments and/or insurance companies in various global settings. The addition of ICD10 codes for the online version will promote a harmonization between the diagnostic tables and coding items that will facilitate bioinformatics research going forward. Acknowledgements The authors wish to thank Dawn Westerfer for the expert secretarial support and Ulrika Smrekova for the administrative support. Compliance with Ethical Standards Conflict of Interest The authors declare that they have no conflicts of interest. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http:// creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. 128 J Clin Immunol (2018) 38:96–128 References 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. Fudenberg H, Good RA, Goodman HC, Hitzig W, Kunkel HG, Roitt IM, et al. Primary immunodeficiencies. Report of a World Health Organization Committee. Pediatrics. 1971;47:927–46. Fudenberg HH, Good RA, Hitzig W, Kunkel HG, Roitt IM, Rosen FS, et al. Classification of the primary immune deficiencies: WHO recommendation. N Engl J Med. 1970;283:656–7. Picard C, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol. 2015;35:696–726. Anonymous. Primary immunodeficiency diseases. Report of a WHO scientific group. Clin Exp Immunol. 1997;109(Suppl 1):1– 28. Chandra R, Cooper M, Hitzig W, Rosen F, Seligmann M, Soothill JF, et al. WHO scientific group on immunodeficiencies. Clin Immunol Immunopathol. 1979;13:296–359. Gatti R. On the classification of patients with primary immunodeficiency disorders. Clin Immunol Immunopathol. 1974;3:243–7. Cooper M, Faulk W, Fudenberg H, Good R, Hitzig W, Kunkel H, et al. Meeting report of the second international workshop on primary immunodeficiency diseases in man. Clin Immunol Immunopathol. 1974;2:416–45. Anonymous. Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies. Clin Exp Immunol. 1999;118(Suppl 1):1–28. Immunodeficiency WSGo: meeting report primary immunodeficiency diseases. Clinical Immunology and Immunopathology 28: 450–475, 1983. Rosen F, Wedgewood R, Eibl M. Primary immunodeficiency diseases. Clin Immunol Immunopathol. 1986;40:166–96. Bousfiha A, Jeddane L, Al-Herz W, Ailal F, Casanova JL, Chatila T, et al. The 2015 IUIS phenotypic classification for primary immunodeficiencies. J Clin Immunol. 2015;35:727–38. Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and diagnosis: guidelines for clinicians at the bedside. J Clin Immunol. 2013;33:1078–87. 13. Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies. Clin Exp Immunol 118 Suppl 1: 1–28, 1999. 14. Notarangelo L, Casanova JL, Fischer A, Puck J, Rosen F, Seger R, et al. Primary immunodeficiency diseases: an update. J Allergy Clin Immunol. 2004;114:677–87. 15. Notarangelo L, Casanova JL, Conley ME, Chapel H, Fischer A, Puck J, et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005. J Allergy Clin Immunol. 2006;117:883–96. 16. Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol. 2007;120:776–94. 17. International Union of Immunological Societies Expert Committee on Primary I, Notarangelo LD, Fischer A, Geha RS, Casanova JL, Chapel H, et al. Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol. 2009;124:1161–78. 18. Al-Herz W, Bousfiha A, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol. 2011;2:54. 19. Primary immunodeficiency diseases. Report of a WHO Scientific Group. Clin Exp Immunol 99 Suppl 1: 1–24, 1995. 20. Stray-Pedersen A, Sorte HS, Samarakoon P, Gambin T, Chinn IK, Coban Akdemir ZH, et al. Primary immunodeficiency diseases: genomic approaches delineate heterogeneous Mendelian disorders. J Allergy Clin Immunol. 2017;139:232–45. 21. Casanova JL, Conley ME, Seligman SJ, Abel L, Notarangelo LD. Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies. J Exp Med. 2014;211:2137–49. 22. Boufiha A, Phenotypical classification of PIDD. 2017. https://play. google.com/store/apps/details?id=com.horiyasoft.pidclassification. 23. Bousfiha A, Phenotypical classification of PIDD, iTunes. 2017. https://itunes.apple.com/us/app/pid-phenotypical-diagnosis/ id1160729399?mt=8. 24. OMIM Online Mendelian Inheritance in Man. https://www.ncbi. nlm.nih.gov/omim.